SRPT FY 2012 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$37M-20.6% YoY

Gross Profit

-$15M-39.1% margin

Operating Income

-$30M-79.6% margin

Net Income

-$121M-324.9% margin

EPS (Diluted)

$-5.14

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$31M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$205M

Total Liabilities

$81M

Stockholders' Equity

$124M

Cash & Equivalents

$188M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$47M	-20.6%
Gross Profit	-$15M	$11M	-232.0%
Operating Income	-$30M	-$36M	+17.3%
Net Income	-$121M	-$2M	-5132.4%